Latest News Archive
Please select Category, Year, and then Month to display items
02 July 2019
|
Story Eloise Calitz
|
Photo Keagan Nkwaira
Audience members listening attentively to the presentations at the Entrepreneurship Inter-varsity on the Bloemfontein Campus.
The UFS continuously creates opportunities for students to develop and explore platforms where they can showcase their talents and share their innovative concepts. In the light of this, it is important for the institution to become a preferred academic knowledge partner that can conceptualise, develop, and successfully commercialise research activities, and through this foster an innovative and entrepreneurial culture that aligns to its Integrated Transformation Plan.
This is why opportunities such as the Entrepreneurship Intervarsity Competition are so important, since it encourages students to demonstrate their entrepreneurial talent, and through this connect with investors and industry leaders to start up a business.
The competition
Student entrepreneurs across the 26 public universities in South Africa were invited to submit their innovative ideas as part of a competition supported by Entrepreneurship Development in Higher Education (EDHE), in collaboration with the Allan Gray Orbis Foundation. The opportunities created through this initiative are twofold:
1. For student entrepreneurs to present their innovative ideas and businesses.
2. For universities to demonstrate their entrepreneurial talent and the ways in which they support and grow the next generation of business leaders.
The competition takes place in five stages. The process started with each student submitting their short videos and applications on the official competition site. Each institution also had the opportunity to select student entrepreneurs to take part in the competition. Fifteen students pitched their ideas during internal rounds at the UFS on 30 May 2019. Of these students, four were selected to represent the UFS at the regional rounds of the Entrepreneurship Intervarsity, where the finalists will be chosen.
The students were judged in four categories:
• Category 1: Innovative Ideas
• Category 2: Tech Businesses (existing businesses, formal or informal, undergrad or postgrad)
• Category 3: Social Impact Businesses (existing businesses, formal or informal, undergrad or postgrad)
• Category 4: General (existing businesses, formal or informal, undergrad or postgrad)
The following UFS entrants were selected to take part in the regional finals:
• Christopher Rothman for his liquid yeast culture that can be used in the fermentation of beer.
• Driaan-Lou Kemp for his patented water-saving device.
• Grace Mthembu for her electricity-saving system.
• Martin Clarke for his idea to use drone technology for the mining industry
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004